XML 33 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

Balance Sheet Components (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Balance Sheet Related Disclosures [Abstract] |
Schedule of Accrued Liabilities | Accrued Liabilities Accrued liabilities consisted of the following:
|  | March 31, |  |  | December 31, |
|  | 2025 |  |  | 2024 |
|  | (in thousands) |
Accrued clinical trial and preclinical costs |  | $ | 11,482 |  |  | $ | 11,606 |
Accrued research and development services ($6.3 million and nil million due to related party in 2025 and 2024, respectively) |  |  | 6,250 |  |  |  | — |
Compensation and benefits |  |  | 6,159 |  |  |  | 9,975 |
Professional services |  |  | 1,972 |  |  |  | 2,686 |
Other |  |  | 409 |  |  |  | 326 |
Total accrued liabilities |  | $ | 26,272 |  |  | $ | 24,593 |

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration